Citação norma APA

Kudo, M. (2018). Extremely High Objective Response Rate of Lenvatinib: Its Clinical Relevance and Changing the Treatment Paradigm in Hepatocellular Carcinoma. Liver Cancer.

Citação norma Chicago

Kudo, Masatoshi. "Extremely High Objective Response Rate of Lenvatinib: Its Clinical Relevance and Changing the Treatment Paradigm in Hepatocellular Carcinoma." Liver Cancer 2018.

Citação norma MLA

Kudo, Masatoshi. "Extremely High Objective Response Rate of Lenvatinib: Its Clinical Relevance and Changing the Treatment Paradigm in Hepatocellular Carcinoma." Liver Cancer 2018.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.